Literature DB >> 6813025

Quantitation of serum immunoglobulins.

D E Normansell.   

Abstract

This article reviews critically the current "state of the art" in the quantitation of immunoglobulins in serum and other body fluids. The methodologies reviewed include (a) those occurring in solution, for example, automated immunoprecipitin and laser nephelometric techniques, rate analysis techniques and radioimmunoassays; (b) techniques involving radial diffusion in agarose gels, with and without secondary development steps; and (c) those techniques involving solid supports, such as fluoroimmunometric assays and solid phase radioimmunoassays. The theory of each technique is presented with an analysis of the strengths and weaknesses, particularly sources of error, and the techniques are compared in terms of accuracy, precision, sensitivity, test cost, equipment cost, feasibility for use in different laboratory settings, and ease of handling. Problems associated with the antisera used, with standards, and with quality controls are discussed and solutions suggested.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6813025     DOI: 10.3109/10408368209107034

Source DB:  PubMed          Journal:  Crit Rev Clin Lab Sci        ISSN: 1040-8363            Impact factor:   6.250


  2 in total

1.  In-Depth Immunological Typization of Children with Sickle Cell Disease: A Preliminary Insight into Its Plausible Correlation with Clinical Course and Hydroxyurea Therapy.

Authors:  Giulia Giulietti; Daniele Zama; Francesca Conti; Mattia Moratti; Maria Teresa Presutti; Tamara Belotti; Maria Elena Cantarini; Elena Facchini; Mirna Bassi; Paola Selva; Elisabetta Magrini; Marcello Lanari; Andrea Pession
Journal:  J Clin Med       Date:  2022-05-27       Impact factor: 4.964

2.  Determinants and Reference Ranges of Serum Immunoglobulins in Middle-Aged and Elderly Individuals: a Population-Based Study.

Authors:  Samer Raza Khan; Layal Chaker; Mohammad Arfan Ikram; Robin Patrick Peeters; Petrus Martinus van Hagen; Virgil Alain Silvester Hovestadt Dalm
Journal:  J Clin Immunol       Date:  2021-09-10       Impact factor: 8.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.